Back

Reversal of residual left ventricular remodeling in corrected primary valvular regurgitation: is it different from dilated cardiomyopathy

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: From infarction to recovery: SGLT2 and rehabilitation in heart failure Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Ruixing Zhang

Chengdu (China)

6 More presentations in this session

Presentation thumbnail
Dapagliflozin attenuates post-infarction inflammation and remodeling via promoting metabolic reprogramming–driven cardiac lymphangiogenesis
Doctor Z. Zhang (CN)
Abstract
Presentation thumbnail
Heart failure therapy optimization in myocardial infarction patients with systolic dysfunction during Phase 2 and 3 Cardiac Rehabilitation
Doctor S. Cardona Tercero (Valencia, ES)
Abstract
Presentation thumbnail
Does symptom profile modify revascularization benefit in ischemic LV dysfunction? A win ratio analysis pooling STICHES and REVIVED-BCIS2
Doctor G. Tong (New Haven, US)
Abstract
Presentation thumbnail
Effects of beta-blocker treatment on circulating biomarkers of fibrosis in patients with myocardial infarction without heart failure: A substudy of the BETAMI-DANBLOCK trial
Professor I. Lunde (Oslo, NO)
Abstract
Presentation thumbnail
Differences in survival outcomes and LVEF of self-expanding versus balloon expandable valves after TAVI in patients with severe cardiac dysfunction
Doctor A. Matta (Toulouse, FR)
Abstract

Access the full session

Session thumbnail
From infarction to recovery: SGLT2 and rehabilitation in heart failure

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Myocardial remodelling and left ventricular recovery after guideline-directed medical therapy in non-ischaemic dilated cardiomyopathy
12 December 2024
thumbnail
Congress Presentation
Disproportionate mitral regurgitation as a predictor of functional outcomes following edge-to-edge repair with the MitraClip system
27 August 2021
thumbnail
Congress Presentation
Sex-differences in left ventricular remodeling and mechanics after aortic valve surgery in patients with severe aortic valve disease
27 August 2021
thumbnail
Congress Presentation
Myocardial phosphoproteomics and single cardiomyocyte force measurements endorse DYRK1A as a candidate therapeutic target for incomplete reverse remodelling after aortic valve replacement
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources